AKYNZEO 260 mg/20mL
Fosnetupitant and Palonosetron · INJECTION · Helsinn Therapeutics (U.S.), Inc.
AKYNZEO is a injection containing fosnetupitant and palonosetron at 260 mg/20mL, taken intravenous. Manufactured by Helsinn Therapeutics (U.S.), Inc..
Key Facts
- Brand Name
- AKYNZEO
- Generic Name
- Fosnetupitant and Palonosetron
- NDC Code (Product)
69639-106- Manufacturer
- Helsinn Therapeutics (U.S.), Inc.
- Strength
- 260 mg/20mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA210493
- Drug Class
- Serotonin-3 Receptor Antagonist [EPC]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- Marketing Start
- 08/01/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is AKYNZEO used for?
AKYNZEO contains Fosnetupitant and Palonosetron. It is a injection taken intravenous. Consult your doctor for specific uses.
Is AKYNZEO a controlled substance?
AKYNZEO is not classified as a controlled substance by the DEA.
What is the generic name for AKYNZEO?
The generic name for AKYNZEO is Fosnetupitant and Palonosetron. There are no other listed brand versions of Fosnetupitant and Palonosetron.
What is the NDC code for AKYNZEO 260 mg/20mL?
The NDC (National Drug Code) for AKYNZEO 260 mg/20mL is 69639-106, listed by Helsinn Therapeutics (U.S.), Inc..
Other AKYNZEO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)